Article Details

Ambrx Presents Phase 1 Trial Data Update and Phase 2/3 Clinical Trial in Progress for Lead ...

Retrieved on: 2020-12-10 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

Ambrx Presents Phase 1 Trial Data Update and Phase 2/3 Clinical Trial in Progress for Lead .... View article details on hiswai:

Excerpt

NovoCodex <b>Biopharmaceuticals</b>, Inc., a majority owned subsidiary of Zhejiang Medicine Co. Ltd. (ZMC), is focused on developing novel next-generation ...

Article found on: www.thepress.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo